Fund Holdings — Aquilo Capital Management, LLC

Total Portfolio Value:
$37.08M
Total Bought:
$7.19M
Total Sold:
$20.54M
Net Transaction:
-$13.35M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Blueprint Medicines Corp129,60083,926-45,674$11.30M$7.43M20.03%-$3.88M
Arrowhead Pharmaceuticals, Inc.(ARWR)707,589550,130-157,459$13.30M$7.01M18.90%-$6.29M
Protagonist Therapeutics Inc76,59281,692+5,100$2.96M$3.95M10.65%+$994.2K
Kymera Therapeutics, Inc.(KYMR)183,521138,521-45,000$7.38M$3.79M10.22%-$3.59M
Precision BioSciences, Inc.(DTIL)536,376726,149+189,773$2.04M$3.46M9.34%+$1.42M
Arvinas, Inc.(ARVN)328,766360,766+32,000$6.30M$2.53M6.83%-$3.77M
REGENXBIO Inc.(RGNX)346,302271,302-75,000$2.68M$1.94M5.23%-$737.1K
Adicet Bio Inc2,531,1942,456,194-75,000$2.44M$1.85M5.00%-$580.6K
Bicycle Therapeutics PlcADS221,911171,695-50,216$3.11M$1.46M3.93%-$1.65M
Immatics N.V.SHS(IMTX)373,902304,902-69,000$2.66M$1.38M3.71%-$1.28M
Repare Therapeutics Inc1,293,7151,293,7150$1.69M$1.28M3.44%-$419.3K
Zymeworks Inc.(ZYME)084,482+84,482$0$1.01M2.71%+$1.01M
Silence Therapeutics plcADS(SLN)367,2140-367,214$2.53M$0—-$2.53M
Sutro Biopharma, Inc.(STRO)4980-498$916$0—-$916
Page 1 of 1
Aquilo Capital Management, LLC — 13F Holdings — Q1 2025 | TickerTrail